ProfileGDS4718 / 203478_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 98% 97% 98% 98% 97% 97% 98% 97% 98% 98% 97% 98% 96% 96% 98% 98% 95% 97% 97% 98% 98% 98% 98% 98% 97% 98% 95% 97% 98% 98% 97% 97% 97% 96% 96% 97% 97% 98% 97% 98% 96% 96% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.637998
GSM549102patient 115, normal, homogenized [OPG study]11.413398
GSM549104patient 119, normal, homogenized [OPG study]11.073397
GSM549108patient 138, normal, homogenized [OPG study]11.264898
GSM549119patient 077, normal, homogenized [OPG study]11.289398
GSM549133patient 032, cancer, homogenized [OPG study]11.159997
GSM549139patient 042, cancer, homogenized [OPG study]10.669297
GSM549099patient 107, normal, homogenized [OPG study]11.266198
GSM549109patient 139, normal, homogenized [OPG study]11.093697
GSM549110patient 046, normal, homogenized [OPG study]11.441198
GSM549114patient 063, normal, homogenized [OPG study]11.543798
GSM549122patient 082, normal, homogenized [OPG study]11.060197
GSM549134patient 033, cancer, homogenized [OPG study]11.132298
GSM549136patient 036, cancer, homogenized [OPG study]10.516996
GSM549140patient 044, cancer, homogenized [OPG study]10.656196
GSM549111patient 047, normal, homogenized [OPG study]11.462398
GSM549113patient 057, normal, homogenized [OPG study]11.647198
GSM549132patient 031, cancer, homogenized [OPG study]10.089995
GSM549137patient 038, cancer, homogenized [OPG study]10.892197
GSM549142patient 047, cancer, homogenized [OPG study]10.346397
GSM549100patient 110, normal, homogenized [OPG study]11.576298
GSM549107patient 135, normal, homogenized [OPG study]11.558798
GSM549115patient 068, normal, homogenized [OPG study]11.590798
GSM549116patient 072, normal, homogenized [OPG study]11.740198
GSM549120patient 078, normal, homogenized [OPG study]11.286998
GSM549131patient 030, cancer, homogenized [OPG study]10.723997
GSM549118patient 074, normal, homogenized [OPG study]11.297398
GSM549129patient 027, cancer, homogenized [OPG study]10.126495
GSM549123patient 088, normal, homogenized [OPG study]11.267397
GSM549124patient 006, cancer, homogenized [OPG study]10.951498
GSM549126patient 015, cancer, homogenized [OPG study]11.112498
GSM549128patient 025, cancer, homogenized [OPG study]10.890897
GSM549103patient 117, normal, homogenized [OPG study]11.011697
GSM549117patient 073, normal, homogenized [OPG study]11.411197
GSM549138patient 041, cancer, homogenized [OPG study]10.467996
GSM549141patient 045, cancer, homogenized [OPG study]10.640696
GSM549130patient 028, cancer, homogenized [OPG study]10.65597
GSM549101patient 111, normal, homogenized [OPG study]11.059997
GSM549105patient 128, normal, homogenized [OPG study]11.309798
GSM549106patient 134, normal, homogenized [OPG study]11.040697
GSM549112patient 048, normal, homogenized [OPG study]11.508198
GSM549125patient 011, cancer, homogenized [OPG study]10.426696
GSM549127patient 024, cancer, homogenized [OPG study]10.520396
GSM549135patient 035, cancer, homogenized [OPG study]10.670796